JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

This paper provides three easy and accessible assays for assessing lipid metabolism in mice.

Streszczenie

Assessing lipid metabolism is a cornerstone of evaluating metabolic function, and it is considered essential for in vivo metabolism studies. Lipids are a class of many different molecules with many pathways involved in their synthesis and metabolism. A starting point for evaluating lipid hemostasis for nutrition and obesity research is needed. This paper describes three easy and accessible methods that require little expertise or practice to master, and that can be adapted by most labs to screen for lipid-metabolism abnormalities in mice. These methods are (1) measuring several fasting serum lipid molecules using commercial kits (2) assaying for dietary lipid-handling capability through an oral intralipid tolerance test, and (3) evaluating the response to a pharmaceutical compound, CL 316,243, in mice. Together, these methods will provide a high-level overview of lipid handling capability in mice.

Wprowadzenie

Carbohydrates and lipids are two major substrates for energy metabolism. Aberrant lipid metabolism results in many human diseases, including type II diabetes, cardiovascular diseases, fatty liver diseases, and cancers. Dietary lipids, mainly triglycerides, are absorbed through the intestine into the lymphatic system and enter the venous circulation in chylomicrons near the heart1. Lipids are carried by lipoprotein particles in the bloodstream, where the fatty acid moieties are liberated by the action of lipoprotein lipase at peripheral organs such as muscle and adipose tissue2. The remaining cholesterol-rich remnant particles are cleared by the liver3. Mice have been widely used in laboratories as a research model to study lipid metabolism. With comprehensive genetic toolsets available and a relatively short breeding cycle, they are a powerful model for studying how lipids are absorbed, synthesized, and metabolized.

Due to the complexity of lipid metabolism, sophisticated lipidomics studies or isotopic tracer studies are usually used to quantify collections of lipid species or lipid-related metabolic fluxes and fates4,5. This creates a massive challenge for researchers without specialized equipment or expertise. In this paper, we present three assays that can serve as initial tests before technically challenging techniques are used. They are non-terminal procedures for the mice, and thus very useful for identifying potential differences in lipid-handling capacity and narrowing down the processes affected.

First, measuring fasting serum lipid molecules can help one ascertain a mouse’s overall lipid profile. Mice should be fasted, because many lipid species rise after meals, and the extent of the increase is strongly affected by the composition of the diet. Many lipid molecules, including total cholesterol, triglyceride, and non-esterified fatty acid (NEFA), can be measured using a commercial kit and a plate reader that can read absorbance.

Second, an oral intralipid tolerance test evaluates lipid-handling capability as a net effect of absorption and metabolism. An orally administered intralipid causes a spike in circulating triglyceride levels (1–2 hours), after which the serum triglyceride levels return to basal levels (4–6 hours). This assay offers information about how well a mouse can handle the exogenous lipids. Heart, liver, and brown adipose tissue are active consumers of triglycerides, whereas white adipose tissue stores it as an energy reserve. Changes in these functions will lead to differences in the test results.

Lastly, promoting lipolysis to mobilize stored lipids is considered a possible strategy for weight loss. The β3-adrenergic receptor signaling pathway in the adipose tissue plays an important role in adipocyte lipolysis, and human genetics have identified a loss-of-function polymorphism Trp64Arg in β3-adrenergic receptor correlated with obesity6. CL 316,243, a specific and potent β3-adrenergic receptor agonist, stimulates adipose tissue lipolysis and the release of glycerol. Evaluation of a mouse’s response to CL 316,243 can provide valuable information on the development, improvement, and understanding of the efficacy of the compound.

Collectively, these tests can be used as an initial screen for changes in the lipid metabolic state of mice. They are chosen for the accessibility of the instruments and reagents. With the results derived from these assays, researchers can form an overall picture of the metabolic fitness of their animals and decide on more sophisticated and targeted approaches.

Protokół

Animals are housed in standardized conditions following animal-care and experimental protocols approved by the Institutional Animal Care and Use Committee of the Baylor College of Medicine (BCM). Animals are fed a standard or special diet, water ad libitum, and kept with a 12-hour day/night cycle.

1. Measuring of fasting serum lipids

  1. Transfer mice to a new cage after 5 PM and fast with free access to water, overnight (with around 16 hours of fasting before the experiment). The overnight fasting ensures complete emptying of the mice’s gastrointestinal tracts.
    NOTE: Mice eat their feces during fasting, so food withdrawal cannot ensure they are adequately fasted.
  2. The next morning, grasp the mouse by the tail and place it on a surface. Pull back gently on the tail of the mouse to place the mouse in the restrainer. Place the nose restraint to retrain the movement of the mouse while still allowing the mouse to breathe. Tighten the knob of the nose restraint. Monitor chest movements to make sure the animal is breathing normally and minimize the time a mouse spends in restrainers.
  3. Make a superficial incision (nick) in the tail vein of the free-moving mouse, and draw 25 µL of blood from the incision into a glass capillary (filling about 1/3 of the capillary) without restraining the mouse. Quickly blow the blood into a microcentrifuge tube.
  4. Stop the bleeding using styptic powders, refill the feed in the cage, and make sure the mice show no signs of stress.
  5. Complete the blood withdrawal for all the mice.
  6. Allow the blood to clot by leaving it undisturbed at room temperature for 1 hour. Spin the clotted blood samples at 2,000 x g at 4 °C for 10 minutes in a refrigerated benchtop microcentrifuge, and transfer supernatant (serum) for analysis.
    NOTE: Serum can be stored at –20 °C for several weeks until analysis. For long-term storage, keep the serum at –70°C.
  7. Analyze each lipid metabolite using the manufacturer’s provided protocol.

2. Oral Intralipid Tolerance Test

  1. After 5 PM, weigh the mice for the calculation of the intralipid volume to be given to them the next day. Then, transfer the mice into a new cage and fast them overnight (16 hours).
  2. The next morning, mark tails of the mice housed in one cage to help identify them in the subsequent bleeding steps.
  3. Make a nick in the tail vein and draw 15 µL of blood from the incision into a glass capillary (filling about 1/5 of the capillary), and quickly blow the blood into a microcentrifuge tube for T = 0 serum.
    NOTE: There is no need to stop the bleeding during the assay unless the mice show excess bleeding.
  4. Gavage mice 20% intralipid using an 18G gavage needle at a ratio of 15 µl per gram of bodyweight, using the pre-fasting bodyweight. Stack each mouse by 1 minute.
    NOTE: Weigh the animal and determine the appropriate gavage needle size. Generally, an 18 gauge gavage needle is appropriate for mice >25 g, and a 20-22 gauge gavage needle would be more appropriate for smaller animals. Scruff the mouse, grasping the skin over the shoulders to hold the animal’s head in place. Place the gavage needle in the mouth and then gently advance along the upper palate, until the esophagus is reached. The tube should pass without resistance. Once proper depth is reached, the Intralipid can be slowly administered. Gently remove the needle following the same angle during needle insertion after administrating the Intralipid. Return the animal to the cage and monitor for signs of labored breathing or other distress.
    NOTE: Researchers who are inexperienced with oral gavage or tail bleeding techniques can stack each mouse by 2 minutes or even longer.
  5. Draw blood at T = 1, 2, 3, 4, 5, and 6 hours: Draw 15 µL of blood (1/5 capillary) per mouse through tail bleeding, and quickly blow the blood into a microcentrifuge tube.
  6. Spin the blood samples at 2,000 x g at room temperature for 10 minutes in a microcentrifuge. Transfer the supernatant, including the floating fat layer, to a PCR tube for storage. The supernatant can be stored at –20 °C for several weeks until analysis.
    NOTE: The supernatant should be plasma. If some samples have already clotted by the time of centrifugation, it does not affect triglyceride measurement.
  7. After the last blood collection, stop the bleeding using styptic powders, refill the feed in the cage, and make sure the mice show no signs of extreme stress.
  8. Load 2 µL of triglyceride standard and collected supernatants into a 96-well plate.
  9. Add 200 µL of triglyceride reagent and let the plate incubate for 5 minutes at 37 °C for color development.
  10. Measure the absorbance at 500 nm with a reference wavelength of 660 nm in a laboratory plate reader, and calculate the sample’s concentration.

3. β3 Adrenergic Receptor Agonist CL 316,243 Stimulated Lipolysis Assay

  1. Prepare CL 316,243 as a stock solution of 5 mg/mL (50x) in sterile saline, and store at –20°C until use.
  2. In the morning, weigh the mice to calculate the amount of diluted CL 316,243 solution needed for the experiment. The mouse will receive 10 µL per gram of bodyweight of diluted CL 316,243, for a final dose of 1 mg/kg bodyweight.
  3. Transfer the mice into a new cage with free access to water, and fast them for 4 hours.
  4. Make enough 1x CL 316,243 solution from 50x stock using saline. The final concentration of 1x CL 316,243 solution is 0.1 mg/mL. Use saline for the control treatment group.
  5. Mark the tails of the mice housed in the same cage for easy identification during the bleeding steps.
  6. Make a nick in the tail vein, and draw 15 µL of blood from the incision into a glass capillary (filling about 1/5 of the capillary), and quickly blow the blood into a microcentrifuge tube for T = 0 sample.
    NOTE: There is no need to stop the bleeding during the assay unless the mice show excess bleeding.
  7. Inject diluted CL 316,243 solution (or control if included in the experiment) intraperitoneally at a volume of 10 µL/g bodyweight. Stack each mouse by 1 minute. Use a maximum of 5 mice for each 60-minute experiment, or 10 mice for a two-person team.
  8. Draw blood at T = 5, 15, 30, 60 minutes: draw 15 µL of blood (1/5 capillary) per mouse through tail bleeding.
  9. After the last blood collection, stop the bleeding using styptic powders, refill the feed in the cage, and make sure the mice show no signs of extreme stress.
  10. Spin blood samples at 2,000 x g at 4 °C for 5 minutes in a refrigerated microcentrifuge. Transfer the supernatant to a PCR tube for storage. The supernatant can be stored at –20°C for several weeks until analysis.
  11. Load 1 µL of 2x serially diluted glycerol standards (0.156, 0.312, 0.625, 1.25, and 2.5 mg/ml Trioleine-equivalent concentrations) and collected supernatants into a 96-well plate. Add 100 µL of free glycerol reagent, and let the plate incubate for 5 minutes at 37 °C for the color to develop.
  12. Measure the absorbance at 540 nm using a laboratory plate reader, and calculate the sample’s concentration.

Wyniki

We show with three excerpts that each assay offers valuable information about the mice's lipid metabolism. For C57BL/6J male mice, challenged by eight weeks of high-fat diet (HFD) feeding  starting at eight weeks of age, total cholesterol levels were significantly elevated, while serum triglyyceride and NEFA were not (Table 1), suggesting that triglyceride and NEFA in the blood are not predominantly regulated by a dietary fat challenge. In the second cohort of mice, C57BL/6J and C57BL6/N su...

Dyskusje

The three assays described function robustly in the lab, with a few critical considerations. Overnight fasting is required for determining fasting serum lipid levels and oral intralipid tolerance test. For oral intralipid tolerance test, it is critical to spin the blood at room temperature to minimize the formation of a fat layer, especially at the 1- and 2-hour time points; it is important not to discard this fat layer if it forms. Make sure to transfer the supernatant with the lipid layer, and pipet gently to mix them ...

Ujawnienia

The authors have nothing to disclose.

Podziękowania

This work is supported by the National Institutes of Health (NIH), grant R00-DK114498, and the United States Department of Agriculture (USDA), grant CRIS: 3092-51000-062 to Y. Z.

Materiały

NameCompanyCatalog NumberComments
20% IntralipidSigma AldrichI141
BD Slip Tip Sterile Syringes 1mlShaotongB07F1KRMYN
CL 316,243 HydrateSigma-AldrichC5976
Curved Feeding Needles (18 Gauge)Kent ScientificFNC-18-2-2
Free Glycerol ReagentSigma AldrichF6428
Glycerol Standard SolutionSigmaG7793
HR SERIES NEFA-HR(2)COLOR REAGENT AFujifilm Wako Diagnostics999-34691
HR SERIES NEFA-HR(2)COLOR REAGENT BFujifilm Wako Diagnostics991-34891
HR SERIES NEFA-HR(2)SOLVENT AFujifilm Wako Diagnostics995-34791
HR SERIES NEFA-HR(2)SOLVENT BFujifilm Wako Diagnostics993-35191
Matrix Plus Chemistry Reference KitVerichem9500
Micro Centrifuge TubesFisher Scientific14-222-168
Microhematrocrit Capillary Tube, Not HeparanizedFisher Scientific22-362-574
NEFA STANDARD SOLUTIONFujifilm Wako Diagnostics276-76491
Phosphate Buffered SalineBoston BioproductsBM-220
Thermo Scientific Triglycerides ReagentFisher ScientificTR22421
Total Cholesterol ReagentsThermo ScientifiTR13421

Odniesienia

  1. Dixon, J. B. Mechanisms of chylomicron uptake into lacteals. Annals of the New York Academy of Sciences. 1207, 52-57 (2010).
  2. Nuno, J., de Oya, M. Lipoprotein lipase: review. Revista Clínica Española. 170 (3-4), 83-87 (1983).
  3. Williams, K. J. Molecular processes that handle -- and mishandle -- dietary lipids. Journal of Clinical Investigation. 118 (10), 3247-3259 (2008).
  4. Burla, B., et al. MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines. Journal of Lipid Research. 59 (10), 2001-2017 (2018).
  5. Umpleby, A. M. Hormone measurement guidelines: Tracing lipid metabolism: the value of stable isotopes. Journal of Endocrinology. 226 (3), 1-10 (2015).
  6. Mitchell, B. D., et al. A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. Journal of Clinical Investigation. 101 (3), 584-587 (1998).
  7. Mahoney, L. B., Denny, C. A., Seyfried, T. N. Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans. Lipids in Health and Disease. 5, 13 (2006).
  8. Hayek, T., et al. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice. Journal of Clinical Investigation. 91 (4), 1665-1671 (1993).
  9. Hogarth, C. A., Roy, A., Ebert, D. L. Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats. Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology. 135 (2), 219-229 (2003).
  10. Tall, A. R. Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk. Journal of Clinical Lipidology. 4 (5), 389-393 (2010).
  11. Singh, A. K., Singh, R. Triglyceride and cardiovascular risk: A critical appraisal. Indian Journal of Endocrinology and Metabolism. 20 (4), 418-428 (2016).
  12. Miller, M., et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 123 (20), 2292-2333 (2011).
  13. Dron, J. S., Hegele, R. A. Genetics of Hypertriglyceridemia. Frontiers in Endocrinology (Lausanne). 11, 455 (2020).
  14. Dole, V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. Journal of Clinical Investigation. 35 (2), 150-154 (1956).
  15. Bartelt, A., et al. Brown adipose tissue activity controls triglyceride clearance. Nature Medicine. 17 (2), 200-205 (2011).
  16. de Souza, C. J., Burkey, B. F. Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Current Pharmaceutical Design. 7 (14), 1433-1449 (2001).
  17. Braun, K., Oeckl, J., Westermeier, J., Li, Y., Klingenspor, M. Non-adrenergic control of lipolysis and thermogenesis in adipose tissues. Journal of Experimental Biology. 221, (2018).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Whole body Lipid handling CapacityLipid MetabolismMetabolic FunctionIn Vivo Metabolism StudiesLipidomic StudiesIsotopic Tracer StudiesLipid Metabolite AnalysisFasting ProtocolBlood WithdrawalTail Vein IncisionIntralipid VolumeGavage TechniqueBlood Collection Time PointsMicrocentrifuge ProcessSupernatant Storage

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone